Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy.

Nicole K ZernRoderick Clifton-BlighAnthony J GillAhmad AnissStan SidhuLeigh DelbridgeDiana LearoydBruce RobinsonMark Sywak

Published in: Annals of surgical oncology (2017)

Patients with BIR following initial treatment for PTC have generally favorable outcomes. Positive IHC for BRAFV600E identifies patients at risk of structural disease recurrence.

Keyphrases

papillary thyroid
lymph node metastasis
squamous cell carcinoma
genome wide
type diabetes
stem cells
combination therapy
replacement therapy
dna methylation
skeletal muscle
mesenchymal stem cells
insulin resistance
squamous cell